Figures and facts

Vita 34 AG is Germany’s oldest and biggest bank for blood of the umbilical cord for private use. The company, which was founded in 1997 as a limited company, has been a joint-stock company since 2002.

About Vita 34

Established in April 1997
Head office and an own stem cell laboratory in Leipzig
101 employees (status 12/2009)
more than 73,000 stored blood of the umbilical cord preparations (status 08/2010)
revenues: EUR 15.1 million
15 applications of stored blood of the umbilical cord in children
Business activities: recovery, preparation, long-term storage of blood and stem cell products for the treatment of various disease patterns
Vita 34 is a 100% subsidiary of Vita 34 International AG. The shareholders of this holding are the founders, the management as well as institutional investors from Germany and the US

Research initiatives

University of Leipzig and IKP Gatersleben:
Dr Michael Cross and Prof Anna Wobus
"Differentiation of stem cells from the blood of the umbilical cord"
Fraunhofer Institute for Cell Therapie and Immunology
Prof Frank Emmerich and Dr Johannes Boltze
"Stroke treatment" and "The therapeutic effectiveness of adult stem cells depending on the age of the cell population and the recipient organism"
Translational Centre for Regenerative Medicine, Leipzig:
Dr Rüdiger Alt
„Establishment and evaluation of VSEL stem cells for tissue repair“
University of Leipzig:
Dr Manja Kamprad
"Proliferation of stem cells from the blood of the umbilical cord"
University of Rostock:
Prof Gustav Steinhoff
"Heart attack treatment"
Technical University of Munich:
Prof Annette-Gabriele Ziegler
"Treatment of diabetes type 1"

Board of Directors

Dr Eberhard Lampeter, CEO
Jörg Ulbrich, CFO

Supervisory Board

Dr Holger Födisch (Chairman)
Richard J. Neeson (Vice Chairman)
Dr Uwe Marx

Scientific Advisory Board

Prof Wolfgang Holzgreve
(Head Physician and President of the Director's Board of the Clinic, University of Freiburg)
Prof Eckart Wunder
(Head of the Laboratory for Stem Cell Research at the Institute for Haematological Research of the CHM-Hôpital du Hasenrain in Mulhouse, France)
Prof Gustav Steinhoff
(Director of the Clinic and Policlinic for Heart Surgery, Medical Faculty of Rostock)

Disclaimer